Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

NCT01902771 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Lack of Accrual

Conditions

Glioma
Brain Cancer
Brain Tumor
Glioblastoma Multiforme
High Grade Glioma

Interventions

BIOLOGICAL: Dendritic Cell Vaccine
BIOLOGICAL: Tumor Lysate
OTHER: Imiquimod
PROCEDURE: Leukapheresis

Sponsor

Edward Ziga